Journal of Bacteriology, August 1999, p. 4780-4789, Vol. 181, No. 16
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Howard Hughes Medical Institute2 and Department of Microbiology and Immunology,1 Albert Einstein College of Medicine, Bronx, New York 10461
Received 13 April 1999/Accepted 15 June 1999
| |
ABSTRACT |
|---|
|
|
|---|
Until recently, genetic analysis of Mycobacterium tuberculosis, the causative agent of tuberculosis, was hindered by a lack of methods for gene disruptions and allelic exchange. Several groups have described different methods for disrupting genes marked with antibiotic resistance determinants in the slow-growing organisms Mycobacterium bovis bacillus Calmette-Guérin (BCG) and M. tuberculosis. In this study, we described the first report of using a mycobacterial suicidal plasmid bearing the counterselectable marker sacB for the allelic exchange of unmarked deletion mutations in the chromosomes of two substrains of M. bovis BCG and M. tuberculosis H37Rv. In addition, our comparison of the recombination frequencies in these two slow-growing species and that of the fast-growing organism Mycobacterium smegmatis suggests that the homologous recombination machinery of the three species is equally efficient. The mutants constructed here have deletions in the lysA gene, encoding meso-diaminopimelate decarboxylase, an enzyme catalyzing the last step in lysine biosynthesis. We observed striking differences in the lysine auxotrophic phenotypes of these three species of mycobacteria. The M. smegmatis mutant can grow on lysine-supplemented defined medium or complex rich medium, while the BCG mutants grow only on lysine-supplemented defined medium and are unable to form colonies on complex rich medium. The M. tuberculosis lysine auxotroph requires 25-fold more lysine on defined medium than do the other mutants and is dependent upon the detergent Tween 80. The mutants described in this work are potential vaccine candidates and can also be used for studies of cell wall biosynthesis and amino acid metabolism.
| |
INTRODUCTION |
|---|
|
|
|---|
Mycobacterium tuberculosis, the agent of tuberculosis, is the leading cause of death in adults worldwide (13). The emergence of drug-resistant strains (47) and the problems associated with tuberculosis in human immunodeficiency virus-infected populations (17) have brought tuberculosis research to the forefront. The development of genetic techniques to study the biology of the organism is an important goal of mycobacterial research.
Considerable effort has gone into the development of allelic-exchange methods to selectively disrupt genes of various mycobacterial species. Several groups have used either small linear DNA fragments (3, 24, 41), long linear DNA fragments (4), or suicidal plasmids (8, 26, 36, 37, 39, 40, 42) to achieve allelic exchange in both fast- and slow-growing mycobacteria. Slow-growing mycobacteria such as M. tuberculosis and Mycobacterium bovis bacillus Calmette-Guérin (BCG) can integrate exogenous DNA into their chromosomes by both illegitimate and homologous recombination (1, 24). Allelic exchange in fast-growing mycobacteria such as Mycobacterium smegmatis is easier than in the slow-growing species; this has led to the idea that the homologous recombination machinery of slow-growing mycobacteria is rather inefficient (31).
Thus far, the only mutants constructed among the slow-growing mycobacterial species are those with genes disrupted with an antibiotic resistance marker. However, in many cases an antibiotic resistance marker may not be desirable. It may not be known whether a gene is essential, and targeted disruption does not let one ascertain essentiality. The failure to obtain a mutant might be due to the failure of the methodology and not to the essentiality of the gene. Furthermore, the possibility of polar effects from an inserted antibiotic resistance marker can prevent the disruption of a nonessential gene if that gene is located in an operon upstream of an essential gene. Also, there are a limited number of antibiotic resistance genes available for use in mycobacteria and making a marked mutation excludes one antibiotic from further consideration. In addition, mutants that are potential vaccine candidates should not contain antibiotic resistance determinants.
An ideal allelic-exchange system is one that can be used for the exchange of unmarked deletion alleles as well as alleles with point mutations. Constructing knockout mutants by in-frame deletions would negate the concerns with using a targeted disruption method. Such mutants are antibiotic sensitive and cannot revert, and the mutations should not be polar on the expression of downstream genes. By extension, the same technique could be used for allelic exchange of point mutations, allowing for a finer dissection of gene function. This type of unmarked allelic-exchange methodology, utilizing a plasmid unable to replicate in the organism of interest and selectable and counterselectable markers (14), has been successfully used for M. smegmatis (26, 39). We wanted to determine if such an allelic-exchange methodology would reproducibly work for the slow-growing mycobacteria M. bovis BCG and M. tuberculosis.
In this study, we describe a new mycobacterial suicide plasmid for allelic exchange of unmarked mutations with sacB sucrose counterselection. This counterselectable marker was previously reported to work for the allelic exchange of marked mutations in M. tuberculosis and M. bovis BCG (8, 38, 40). In this work, we demonstrate the reproducibility of allelic exchange of unmarked deletions in the chromosome of M. bovis BCG and M. tuberculosis. We chose to construct lysine auxotrophs of these two slow-growing mycobacteria and M. smegmatis, by allelic exchange of lysA, the gene encoding meso-diaminopimelate (DAP) decarboxylase, the last enzyme in the lysine biosynthetic pathway (51). We compared the kinetics of homologous recombination in these species and found that the frequency of allelic exchange at the lysA locus was remarkably similar among the three organisms. We also examined the nutritional requirements of the lysine auxotrophs and found striking differences among these mutants. To the best of our knowledge, this is the first report of the construction of unmarked deletion mutations in the genomes of slow-growing mycobacteria and the first direct comparison of the same allelic-exchange technique in both slow- and fast-growing mycobacteria. The results from this study suggest that the homologous recombination machinery in slow- and fast-growing mycobacteria may function with similar efficiency.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains and culture methods.
The bacterial strains
used in this study are listed in Table 1.
The genetic nomenclature for strains bearing an integrated suicide
plasmid (DUP) was previously described (36).
Escherichia coli cultures were grown in Luria-Bertani (LB)
broth or on LB agar (Difco). Mycobacterial cultures were grown in
Middlebrook 7H9 broth (Difco) with 0.05% Tween 80, on 7H9 medium
solidified with 1.5% agar, or on Middlebrook 7H10 or 7H11 medium
(Difco). All cultures were incubated at 37°C. All Middlebrook media
were supplemented with 0.2% (vol/vol) glycerol and with 1× ADS (0.5% bovine serum albumin, fraction V [Boehringer Mannheim]; 0.2%
dextrose; and 0.85% NaCl) for M. bovis BCG and M. tuberculosis cultures. Our basal media were 7H9 and 7H10
supplemented as described above. Sucrose was used in medium at a
concentration of 2% (wt/vol), added after the medium was autoclaved
and cooled to 55°C. Casamino Acids (acid-hydrolyzed casein; Difco)
were used at a concentration of 0.2% (wt/vol). Individual amino acids
were obtained from Sigma Chemical (St. Louis, Mo.) and used at a
concentration of 40 µg/ml, unless indicated otherwise. The lysine
analog S-(
-aminoethyl)-L-cysteine (AEC) was
obtained from Sigma Chemical, dissolved in water, and used at a
concentration of 3 mM. When required, the following antibiotics were
used at the specified concentrations: carbenicillin (50 µg/ml,
E. coli), kanamycin A monosulfate (25 µg/ml, E. coli, M. smegmatis, and M. bovis BCG),
hygromycin B (50 µg/ml, E. coli, M. bovis BCG,
and M. tuberculosis; 150 µg/ml, M. smegmatis).
Hygromycin B was purchased from Boehringer Mannheim (50 mg/ml in
phosphate-buffered saline), and all other antibiotics were purchased
from Sigma Chemical. Note that we often found that pYUB412- and
pYUB405-based plasmids were stable in E. coli only with use
of both carbenicillin and hygromycin at 50 µg/ml in solid and liquid
media. M. smegmatis plates were incubated for 3 to 5 days,
while M. bovis BCG and M. tuberculosis plates
were incubated for 3 to 4 weeks. M. bovis BCG and M. tuberculosis starter cultures were inoculated by using 1-ml frozen
stocks in 10 ml of medium in 30-ml plastic medium bottles and incubated
for 5 to 7 days on a shaker platform at 100 rpm. Larger cultures were
inoculated from the starter cultures at a 1:50 dilution in 50 or 100 ml
of medium within 490-cm2 roller bottles (Corning) and
incubated on a roller apparatus at 8 rpm for 5 to 7 days. For growth
curves, mid- to late-exponential-phase cultures were centrifuged and
washed with fresh medium lacking supplements, and the cells were
resuspended appropriately and inoculated into test medium. Samples of
M. tuberculosis and BCG cultures were mixed 1:1 with 10%
phosphate-buffered formalin and fixed for at least 1 h prior to
spectrophotometric measurement of optical density at 600 nm.
|
DNA methodologies.
DNA manipulations were done essentially
as previously described (28). The plasmids used in this
study are listed in Table 2. Plasmids
were constructed in E. coli HB101 or DH5
cells and prepared by an alkaline lysis protocol (21). Plasmids used
for recombination were purified with Qiagen columns as recommended by
the manufacturer (Qiagen, Inc., Chatsworth, Calif.). DNA fragments used
for plasmid construction were purified by agarose gel electrophoresis and recovered by absorption to a silica matrix (GeneClean; Bio 101, Vista, Calif.).
|
-mercaptoethanol added to a final concentration of 1% prior to
use). The upper phase was collected after centrifugation, and the
genomic DNA was precipitated with isopropanol. Southern blotting and
hybridization were done as previously described (36).
Oligonucleotides for sequencing and PCR were synthesized by the Albert
Einstein College of Medicine oligonucleotide synthesis facility.
Cloning and sequencing of the M. smegmatis lysA
operon.
We used a library of genomic DNA from wild-type M. smegmatis mc2155 constructed in the cosmid vector
pYUB412 to clone the lysA gene. The vector pYUB412 is an
integration-proficient, PacI-excisable cosmid vector
(5). This cosmid vector has the mycobacteriophage L5
attachment site (attP), the L5 integrase gene
(int), and the hyg gene, conferring resistance to
hygromycin. This vector efficiently integrates into the
mycobacteriophage L5 attachment site (attB) of the
mycobacterial chromosome and is stable (27). The
pYUB412::mc2155 library was electroporated into
the strain MCK3037, a lysine auxotrophic mutant of mc2155
generated by ethyl methanesulfonate mutagenesis (32).
Transformants were selected on 7H10 medium lacking lysine, and
Lys+ clones were screened for the hygromycin resistance
marker carried on the cosmid vector backbone. One Lys+
Hygr clone was chosen for study, and the genomic DNA insert
within the integrated cosmid was recovered by
in vitro packaging
(GigaPak III; Stratagene). The recovery procedure was as follows. The
library insert DNA was flanked by PacI restriction
endonuclease sites present in the cosmid vector, and since
PacI sites do not exist in mycobacterial genomic DNA
(25), PacI digestion of the genomic DNA releases
the cosmid insert DNA. This DNA fragment was repackaged into
PacI-digested arms of the cosmid vector pYUB412 by
in
vitro packaging, and a new cosmid (pYUB601) with the insert was
recovered in E. coli. The cosmid pYUB601 insert DNA was
subcloned into a 4.4-kb EcoRI fragment bearing the
lysA gene in plasmid pYUB604. The plasmid pYUB604 and two
subclones, pYUB605 and pYUB607, were templates for DNA sequencing with
the Applied Biosystems Prism Dye Terminator Cycle Sequencing Core kit
with AmpliTaq DNA polymerase (Perkin-Elmer) and an Applied Biosystems
377 automated DNA sequencer. Sequence data for both strands of the
lysA operon of M. smegmatis were obtained from
these subclones and by primer walking.
Construction of sacB suicide vector pYUB657. A 2.5-kb PstI fragment from the E. coli sacB vector pCVD442 bearing sacB and its upstream regulatory region sacR were subcloned into the PstI site of the shuttle vector pMV261 downstream of the mycobacterial groEL (Hsp60) promoter, yielding the plasmid pYUB631. A 3.5-kb NotI-NheI fragment from pYUB631, bearing PgroEL-sacB, was cloned into the cosmid vector pYUB405, resulting in the final construct pYUB657 (see Fig. 1). The vector pYUB405 is a PacI-excisable cosmid vector unable to replicate in mycobacteria and encodes resistance to ampicillin and hygromycin (5).
Construction of the M. smegmatis
lysA4 suicide
plasmid pYUB618.
The plasmid pYUB604 was used as the template in
an inverse PCR to produce a deletion within the lysA gene.
Oligonucleotide primers Pv44 (5'-CCCGTCGTACGTACGAACCAGGTTGCGC-3')
and Pv45 (5'-CGAGTCGATACGTACTGCTGTGCCGCCC-3') were
used at 50 pmol each in an inverse XL-PCR in a Perkin-Elmer 9600 temperature cycler with the following program: 95°C for 5 min, 1 cycle; 93°C for 1 min and 68°C for 5 min, 16 cycles; 93°C for 1 min and 68°C for 5 min with the time increasing by 15 s for each
cycle, 12 cycles; 72°C for 30 min. The reaction produced a 7.7-kb
fragment with a 1.2-kb deletion within the lysA open reading
frame (spanning nucleotide positions 2051 to 3251 of the sequence with
GenBank accession no. AF126720) marked with a unique SnaBI
site. The PCR product was gel purified, digested with SnaBI,
and self-ligated to yield the plasmid pYUB617. A 3.2-kb EcoRI fragment from pYUB617 bearing the
lysA4
allele was cloned into the PacI sites of the mycobacterial
sacB suicide vector pYUB657, resulting in the M. smegmatis
lysA4 suicide plasmid pYUB618.
Construction of the M. bovis BCG-M.
tuberculosis
lysA5::res suicide plasmid
pYUB668.
The lysA gene of M. tuberculosis
was originally cloned and sequenced by Andersen and Hansen
(2). The plasmid pET3d.lysA contains the
lysA gene of M. tuberculosis Erdman cloned by PCR with primers designed on the basis of the previously published sequence
(2, 15). A 1.3-kb XbaI-BamHI fragment
bearing the lysA gene was cloned from pET3d.lysA
into the same sites in pKSI+ to produce pYUB635. This
plasmid was used as the template in an inverse PCR with the
oligonucleotide primers Pv7
(5'-GATAGCGGTCACGCGTCTCGTGCGCGGTGGA-3') and Pv8
(5'-TCCGTACGATACGCGTCAGCCACATCGGTTCG-3') to generate a 95-bp
deletion within the lysA gene marked with a unique
MluI restriction endonuclease site. The inverse XL-PCR was
done with a Perkin-Elmer 9600 temperature cycler and the program
described above for plasmid pYUB617. The resulting 4.1-kb PCR product
was gel purified, digested with MluI, and self-ligated to
yield the plasmid pYUB636. The lysA deletion was marked with
the aph gene, conferring kanamycin resistance, by insertion
of a specialized aph cassette via the unique MluI
site to yield pYUB638. This specialized cassette has an aph
gene flanked by two 
resolvase sites from the E. coli
transposon 
(Tn1000) (19). The presence of
the resolvase sites made it possible to excise the antibiotic
resistance marker by expressing the 
resolvase in mycobacteria
after the cassette had been inserted into the mycobacterial chromosome
(7). For the purposes of this study, however, the
res-aph-res marker was removed from pYUB638 by resolvase
excision in E. coli DH5
prior to introduction into
mycobacteria (see below).
lysA allele, we used cosmid cosY373 from the Sanger Centre
M. tuberculosis H37Rv genome sequencing project
(11). An 11-kb SnaBI fragment from cosY373,
containing lysA situated in the middle, was subcloned into
the EcoRV site of pKSI+ to yield plasmid
pYUB659. To replace the wild-type lysA allele in pYUB659
with the
lysA::res-aph-res allele
constructed above in pYUB638, we exchanged an internal
NheI-BglII fragment of lysA encompassing the deletion region between these two plasmids. Because there is an additional NheI site at the 5' end of the
res-aph-res cassette, this exchange resulted in an
additional deletion of 236 bp within the lysA gene. The
resulting plasmid, pYUB665, contains a deletion within lysA
totaling 331 bp and the res-aph-res cassette. We passaged
the plasmid pYUB665 in E. coli DH5
(which has a 
element capable of excising the aph gene from the
lysA::res-aph-res allele) and
isolated a Kns derivative, plasmid pYUB667. DNA sequence
analysis of pYUB667 showed that the aph cassette was absent
and that a single res site that was in frame with respect to
the lysA open reading frame remained. The mutant
lysA allele in pYUB667 is designated
lysA5::res and has a total deletion
of 331 bp of an internal portion of the lysA gene, but with
the addition of the 136-bp res site, the net change in size
of
lysA5::res compared to the wild
type is a decrease of 195 bp. To produce the final suicidal plasmid for
allelic exchange in M. bovis BCG and M. tuberculosis, an 8.4-kb HpaI fragment from pYUB667 was
cloned into the PacI sites of the sacB suicidal
vector pYUB657, resulting in plasmid pYUB668. This plasmid has
approximately 4 kb of DNA flanking each side of the
lysA5::res allele.
Electroporation of mycobacteria. M. smegmatis was electroporated as previously described (36). M. bovis BCG and M. tuberculosis were electroporated as described for M. smegmatis, except that all manipulations were done at room temperature instead of on ice and the expression step proceeded overnight for approximately 12 h prior to plating. For recombination experiments, 1 µg of covalently closed supercoiled plasmid DNA was used for each electroporation.
Nucleotide sequence accession number. The DNA sequence of the 4,462-bp EcoRI fragment encoding the M. smegmatis lysA gene was submitted to GenBank and assigned the accession no. AF126720.
| |
RESULTS |
|---|
|
|
|---|
Allelic-exchange methodology. Our basic procedure for making mutants with the sacB suicidal vector pYUB657 (Fig. 1) is a two-step allelic exchange (14, 36). A suicidal recombination plasmid is electroporated into cells, and primary recombinants are selected upon hygromycin medium. Since the plasmid cannot replicate, any hygromycin-resistant clones must have integrated the plasmid into the chromosome by a single-crossover event. Because of the presence of the sacB gene on the pYUB657 vector backbone, the Hygr clones are also sensitive to sucrose (Sucs). Plasmid integration at the desired locus results in a tandem duplication (given the designation DUP) of the cloned region with the vector DNA in the middle. One such DUP clone is grown to saturation in supplemented medium, during which time individuals within the population undergo a second homologous recombination event between the duplicated regions. In this event, the plasmid vector is lost along with the hyg and sacB genes, leaving behind either the wild-type or the mutant allele, depending upon which side of the mutation the second recombination event occurred. This second recombination event occurs at a low frequency; thus, there must be a selection for the desired secondary recombinants. To select these clones, one takes advantage of the loss of the sacB gene; any clone losing the plasmid is now sucrose resistant (Sucr). The culture is plated on supplemented medium containing sucrose to kill any clones that did not undergo a second recombination event. The sucrose-resistant clones are then screened for hygromycin sensitivity and the mutant phenotype.
|
Cloning of the mycobacterial lysA genes. For this study, we chose to test our system by constructing lysine auxotrophs via deletion of the lysA gene, encoding meso-DAP decarboxylase, in M. smegmatis, M. bovis BCG, and M. tuberculosis. The lysA gene of M. tuberculosis was already available and could also be used for allelic exchange in M. bovis BCG due to the conservation of DNA sequences between the two species; however, the lysA gene of M. smegmatis was not available. We cloned the M. smegmatis lysA gene and resident operon as described in Materials and Methods. The lysA gene of M. smegmatis is 1,424 bp in length and has 77% homology with the lysA gene of M. tuberculosis, while the two LysA proteins have an 80% identity (16). The structure of the lysA operon is conserved among several mycobacteria and the related organism Corynebacterium glutamicum. In M. tuberculosis, the gene order is as follows: argS (arginyl-tRNA synthetase), lysA (meso-DAP decarboxylase), hdh (homoserine dehydrogenase), thrC (threonine synthase), PGRS-17 [poly(GC)-rich repeat 17], and thrB (threonine kinase) (43). Our sequence from M. smegmatis spans from upstream of argS through the hdh gene. A similar argS-lysA operon arrangement is seen for Mycobacterium leprae (36) and Brevibacterium glutamicum (renamed C. glutamicum) (34). The hdh gene product supplies homoserine, the precursor for Met and Thr biosynthesis (29), while the thrC and thrB genes are responsible for threonine synthesis (35).
Construction of an unmarked lysA deletion mutant of
M. smegmatis.
We electroporated M. smegmatis
mc2155 with the
lysA4 suicidal plasmid
pYUB618 (see Materials and Methods for plasmid construction) and
obtained an average of 15 Hygr clones per transformation,
with primary recombination efficiencies of 10
5 (Table
3). Two cultures of one strain,
mc21492, were grown to saturation in 7H9-lysine medium, and
dilutions were plated onto 7H10-lysine medium supplemented with
sucrose. We obtained sucrose-resistant clones at a frequency of
10
4; screened 100 clones from each set for
Sucr, Hygs, and auxotrophy; and found three
basic phenotypes: Sucr Hygr prototrophic,
Sucr Hygs prototrophic, and Sucr
Hygs auxotrophic (Table 4,
experiments 1 and 2). The largest group was the Sucr
Hygr prototrophic class, which likely resulted from
inactivation of the sacB gene, since the clones were still
resistant to hygromycin and did not appear to have arisen from a
secondary recombination event. The other two Sucr classes
were Hygs and appeared to result from secondary
recombination events; the first class retained the wild-type allele,
while the second class retained the mutant allele and was auxotrophic
for lysine. One mutant was given the designation mc21493,
and allelic exchange of lysA was confirmed by Southern
blotting (Fig. 2A). The mutant grows
equally well on defined 7H9 medium supplemented with lysine and on
complex medium (7H9 supplemented with Casamino Acids or LB medium).
|
|
|
Construction of an unmarked lysA deletion mutant of
M. bovis BCG substrain Pasteur.
We used the suicide
plasmid pYUB668 (see Materials and Methods) to construct an unmarked,
in-frame deletion of lysA
(
lysA5::res) in the genome of
M. bovis BCG substrain Pasteur. After electroporation of BCG
substrain Pasteur with the suicide plasmid, we obtained an average of
five Hygr clones per transformation with a primary
recombination efficiency of 10
4 (Table 3). We screened
several Hygr Sucs clones by PCR to determine
which of the primary clones were homologous recombinants. The PCR
screen used an oligonucleotide primer specific for the res
site at the deletion site and primers specific for the chromosomal DNA
sequences flanking the insert DNA cloned into the suicide plasmid.
Three of four clones examined had incorporated the suicide plasmid
pYUB668 at the lysA locus, while the fourth appeared to be
the result of an illegitimate recombination event (data not shown). We
chose two clones for further study,
mc21601(DUP3) and
mc21602(DUP4), both of which had integrated
pYUB668 at lysA but had differed in the orientation of the
duplication (Table 1). The two strains were grown to saturation in 7H9
medium supplemented with lysine, methionine, and threonine and then
plated upon the same type of medium containing sucrose. We used this
combination of amino acids to ensure that any unforeseen polar effect
of the
lysA5::res allele on the
downstream Met and Thr biosynthetic genes would not prevent the
isolation of mutants. The results of the sucrose selection are shown in
Table 4, experiments 3 and 4. We obtained Sucr clones at a
frequency of 10
4 and observed the same three classes of
secondary recombinants that we saw in the M. smegmatis
experiments. Allelic exchange was confirmed in strain
mc21604, a mutant derived from DUP3 strain
mc21601 (see Southern blot in Fig. 2B). The auxotroph
mc21604 does not revert, and no suppression was observed in
two independent cultures of 5 × 109 CFU each.
Use of allelic exchange to distinguish homologous from illegitimate primary recombinants. When using the two-step allelic-exchange methodology with the slow-growing mycobacteria, it is important to identify primary recombinants that resulted from illegitimate recombination and those which resulted from homologous recombination. This can be done by PCR screening (as we did for the above-described experiment) or Southern blotting, although these screening methods are difficult when using large recombination substrates. We reasoned that it should be possible to distinguish between the two types of recombinants by observing the phenotypic frequencies in the pool of Sucr secondary clones. Presumably, any primary recombinant resulting from a homologous integration of the plasmid at lysA would be able to undergo a second recombination event and lose the plasmid, while a recombinant that had integrated the plasmid via illegitimate recombination would be unable to do the same. Any Sucr clones arising from an illegitimate recombinant would result from inactivation of the sacB gene as seen above, and all these clones should also be Hygr.
We tested this idea in a series of lysA allelic-exchange experiments with M. bovis BCG substrain Connaught. Electroporation of BCG substrain Connaught with the suicide plasmid pYUB668 yielded an average of two Hygr clones per electroporation for a primary recombination efficiency of 10
3 (Table 4). We chose seven Hygr
Sucs BCG substrain Connaught::pYUB668 primary
recombinants, grew them in medium supplemented with lysine, plated for
sucrose-resistant clones, and then screened the Sucr clones
for hygromycin sensitivity and auxotrophy (Table 4, experiments 9 through 15). Three of the seven primary recombinants (clones 3, 9, and
10) gave rise to phenotypic populations similar to that seen for
M. bovis BCG substrain Pasteur DUP strains
mc21601 and mc21602 (compare results in Table
4). Therefore, these three primary clones (3, 9, and 10) were
homologous primary recombinants. Two clones (2 and 11) yielded only
Sucr Hygr prototrophs, while the remaining
clones (4 and 8) yielded a majority of Sucr
Hygr prototrophs and a small number of Sucr
Hygs prototrophs (Table 4). These four primary clones (2, 4, 8, and 11) were therefore classified as illegitimate recombinants.
One BCG substrain Connaught lysine auxotroph, derived from clone 3, was
designated strain mc22519, and allelic exchange was
confirmed by Southern blotting (Fig. 2B).
Construction of an unmarked, in-frame lysA deletion
mutant of M. tuberculosis H37Rv.
The same methodology
and suicide plasmid, pYUB668, described above were used to construct a
lysA deletion mutant of M. tuberculosis H37Rv. We
observed primary recombination efficiencies that were similar to those
observed in experiments with BCG substrain Pasteur (Table 3). We chose
six Hygr Sucs primary recombinants, grew them
in lysine-supplemented medium, and plated for sucrose-resistant
recombinants. All six primary recombinants gave rise to phenotypic
populations, similar to the results seen with the BCG substrain Pasteur
mc21601 DUP3 strain grown in basal medium and
shown in Table 4, experiment 5 (data not shown). We concluded that
these primary clones were all likely homologous recombinants but that
something was wrong with the system, since we did not isolate any
auxotrophs. The sucrose selection was repeated with two of these
primary recombinant strains, mc22998 and
mc22999, grown in several types of medium: basal, Lys,
Met-Thr-Lys, and Casamino Acids (Table 4, experiments 16 through 23).
In the subsequent experiments, the frequency of sucrose resistance was in the range of 10
5 to 10
4 (Table 4).
Again, we failed to obtain auxotrophs and confirmed that the phenotypic
frequencies within the Sucr population were similar to
those in the experiment that failed to yield Lys
BCG
mutants on basal medium (compare experiments 17 and 18 with experiment
5 in Table 4). Furthermore, the results from the M. tuberculosis primary recombinants were unlike the results obtained with the M. bovis BCG substrain Connaught illegitimate
primary recombinants. These results suggested to us that all our
primary recombinants were indeed homologous but that for some reason
any auxotrophs resulting from a secondary recombination event were nonviable. Apparently, the medium could not support the growth of an
M. tuberculosis lysine auxotroph. We decided to determine if
our inability to isolate a lysine auxotroph of M. tuberculosis was due to the inability of the organism to transport lysine.
Transport of lysine in mycobacteria. To investigate lysine transport in M. tuberculosis, we used the toxic lysine analog AEC. AEC is transported via lysine importers; the lysine permeases of E. coli (LysP) and C. glutamicum (LysI) were identified by using AEC-resistant mutants (45, 48). AEC inhibits aspartokinase, the enzyme catalyzing the first step of the aspartate amino acid family pathway responsible for the synthesis of Met, Thr, Ile, Lys, and meso-DAP, the last being a component of the cell envelope peptidoglycan and the precursor to lysine (23, 44). AEC alone is capable of inhibiting the growth of E. coli but requires the addition of threonine to inhibit the growth of corynebacteria (44). Presumably, full AEC sensitivity in corynebacteria requires repression of the threonine branch of the pathway by threonine.
The growth curves of M. tuberculosis H37Rv and M. bovis BCG substrain Pasteur in media with or without AEC and Thr are shown in Fig. 3. We used a molar concentration of 3 mM for AEC and Thr, a concentration that is close to the 40 µg/ml used for amino acid supplementation in our studies. As seen in Fig. 3, neither AEC nor Thr alone has an inhibitory effect upon the growth of the two species; however, the combination of the two does inhibit growth, with M. bovis BCG experiencing the greatest inhibition compared to that of M. tuberculosis. One interpretation of the results of this experiment is that lysine uptake is not as efficient in M. tuberculosis as in M. bovis BCG. The BCG lysine auxotrophic mutant mc21604 does not grow well in medium supplemented with lysine at concentrations below our standard concentration of 40 µg/ml (data not shown). This suggests that a decrease in transport efficiency of M. tuberculosis compared to that of M. bovis BCG might preclude us from isolating an M. tuberculosis lysine auxotroph. Since our inability to isolate a lysine auxotroph of M. tuberculosis might be due to inefficient lysine transport by the organism, we made another attempt by using medium with increased amounts of lysine.
|
Identification of media that support the growth of an M. tuberculosis H37Rv lysine auxotroph. Allelic exchange with the M. tuberculosis pYUB668-carrying homologous primary recombinant strain mc22998 was repeated with modified media with increased amounts of lysine. Experiments utilizing media containing lysine at 200 µg/ml, at 200 µg/ml with 0.05% Tween 80, or at 1 mg/ml did not yield any auxotrophs (Table 4, experiments 24 to 26). However, auxotrophic mutants were isolated when medium containing lysine at 1 mg/ml with 0.05% Tween 80 was used (Table 4, experiment 27). The mutant colonies were much smaller than were the wild-type colonies and were easily identified on the sucrose selection plates (Table 4, experiment 27).
One mutant was designated mc23026, and allelic exchange of lysA was confirmed by Southern blotting (Fig. 2B). No reversion or suppression was seen in 3 × 109 CFU. The mutant grows slowly, requiring approximately 4 to 5 weeks to form a large colony on solid medium, and has an approximate doubling time of 48 h in liquid medium (data not shown). Surprisingly, the mutant can grow on 7H10 solid medium supplemented with Casamino Acids and also on 7H11 (supplemented with Casitone, a pancreatic digest of casein) but requires high concentrations of lysine if lysine is the sole supplement. It has an absolute dependency upon Tween 80 regardless of the type of solid medium.| |
DISCUSSION |
|---|
|
|
|---|
Several groups have demonstrated the use of suicide plasmids for allelic exchange in fast- and slow-growing mycobacteria. The most efficient are those systems using a counterselectable marker; for mycobacteria, workers have successfully used rpsL (36, 42), pyrF (26), and sacB (40). The most promising counterselectable system for the slow-growing mycobacteria is sacB, which confers sensitivity to sucrose. Methods using sacB were used for the targeted disruptions of ureC in M. bovis BCG (40) and M. tuberculosis (37) and the erp gene of M. bovis BCG and M. tuberculosis (8).
We decided to construct a new sacB suicidal vector, pYUB657, and test it for the construction of unmarked, in-frame deletion mutants in the slow-growing mycobacteria. In these studies, we saw an opportunity to examine homologous recombination in the mycobacteria from a practical standpoint. The bane of allelic exchange in slow-growing mycobacteria has been the propensity with which these organisms incorporate exogenous DNA into their genome via illegitimate recombination (1, 24, 31). Allelic exchange in M. smegmatis is relatively easy, and this species does not appear to integrate DNA via illegitimate recombination. Several workers have suggested that the homologous recombination machinery is rather inefficient in the slow-growing mycobacteria. It is generally believed that illegitimate recombination occurs at a higher frequency than does homologous recombination in the slow-growing mycobacteria, but this does not necessarily mean that homologous recombination is defective in these organisms (31).
The results of this work suggest that homologous recombination in
M. bovis BCG and M. tuberculosis is as efficient
as that in M. smegmatis. First, the frequency of integration
of suicidal plasmids into the chromosomes of the fast and slow growers
is similar, within the range of 10
4 to 10
5
(except for BCG substrain Connaught, the frequency of which was 10
3; this might be an inflated value, however, due to an
unusually low electroporation efficiency with the control vector
pYUB412). While the number of primary recombinants obtained in M. bovis BCG and M. tuberculosis is lower than that
obtained in M. smegmatis, the differences in the numbers of
primary recombinants and recombination frequencies are small, and the
electroporation frequencies are, at best, only an approximation. We
suspect that any significant differences in primary recombination
frequencies between slow-growing mycobacteria and M. smegmatis likely reflect a difference in DNA entry into the cells,
since it is generally agreed that higher electroporation efficiencies
are possible with M. smegmatis than with the slow growers.
The primary recombination frequencies for the slow-growing mycobacteria include both homologous and illegitimate recombinants; thus, a direct comparison between the frequencies of primary recombination in fast- and in slow-growing mycobacteria may not be valid. However, we think that more illegitimate recombination occurs with linear DNA than with plasmid DNA; thus, the contribution of illegitimate recombination to the primary recombination frequencies is likely to be small. The recombination experiments described in this work used covalently closed, supercoiled plasmid DNA. In preliminary work (data not shown), we found that electroporation of linear insert DNA from our recombination plasmids into BCG yielded 10-fold more clones than did electroporation with the covalently closed circular plasmids, but all the clones obtained with linear DNA were illegitimate recombinants. In addition, we rarely obtained hygromycin-resistant clones when we electroporated the sacB suicide vector pYUB657 lacking a DNA insert for recombination into M. bovis BCG or M. tuberculosis (data not shown). The difference in recombination results with linear substrates and covalently closed circular DNA substrates may be due to linear DNA being more recombinogenic than circular DNA, since it has free ends available for strand invasion (31). The illegitimate recombination mechanism in slow-growing mycobacteria is not characterized in any detail, but we hypothesize that the illegitimate recombination machinery may be relatively more sensitive to linear DNA than is the homologous recombination machinery. In this view, linear DNA might stimulate illegitimate recombination to a much higher degree than homologous recombination.
Comparing homologous recombination frequencies among these three
species is more straightforward when one examines the frequencies of
secondary recombination events. When we subjected cultures to sucrose
selection, we obtained sucrose-resistant clones in the range of
10
4 to 10
5 for all three species, the same
as the frequency seen for the primary recombination of the plasmid into
the chromosome. In the sucrose-resistant population, we observed three
phenotypic classes, two of which resulted from a recombination event
and one that we believe did not. The latter class, the Sucr
Hygr prototrophs, was designated
"sacB-inactivated" clones, since they were still
hygromycin resistant. Inactivation of sacB in BCG, at a
frequency similar to that observed in this study, has been noted
previously (40). Counterscreenable markers can be inactivated at an approximate frequency of 10
5 in
M. smegmatis by the action of mobile insertion elements
(10). We have also seen a similar phenomenon, at a lower
frequency, with use of the rpsL system for allelic exchange
in M. smegmatis (36).
In this study, we sought to construct mutants with a deletion in lysA, conferring a lysine auxotrophic phenotype. Unexpectedly, the lysine auxotrophs that we obtained in this study have different lysine requirements. The M. smegmatis mutant is the most flexible in its requirements, growing on chemically defined medium supplemented with lysine as well as on medium supplemented with Casamino Acids. In contrast, we could not isolate auxotrophs of BCG substrain Pasteur by using Casamino Acids-containing medium. The compositional analysis of the Casamino Acids used in this study showed that our medium should have a lysine concentration that is threefold greater than the amount required for the BCG lysine auxotrophs (12). Neither the BCG substrain Pasteur nor the BCG substrain Connaught lysine auxotrophs are able to grow on solid medium if Casamino Acids or Casitone (a pancreatic digest of casein) is used as the source of lysine. Previously studied Met and Leu auxotrophic mutants of BCG can grow on casein medium, unlike the BCG lysine auxotrophs described in this study (24, 30). In more recent work with transposon mutagenesis of BCG, there were attempts to assay the efficiency of mutagenesis by screening for amino acid auxotrophy (6). The only mutants that were obtained were Leu auxotrophs, as isolated previously. This led to some concern that the transposition mechanism might not be random, which would be detrimental to a mutagenesis system (5). However, all of these attempts utilized medium containing casein preparations. Under such conditions, lysine auxotrophs would not be isolated. It is possible that the casein phenomenon described here is more widespread and could explain the dearth of auxotrophs in the above-described experiments. We are currently investigating why the BCG lysine auxotrophs fail to grow on medium containing casein.
We were unable to isolate lysine auxotrophs of M. tuberculosis H37Rv until we used medium with a high concentration of lysine and 0.05% Tween 80. As was the case for M. bovis BCG, we could not isolate M. tuberculosis mutants by using Casamino Acids; however, once we obtained a mutant, we found that it could grow on Casamino Acids medium or Casitone, as long as there was Tween 80 in the medium. Since the M. tuberculosis mutant is dependent upon the presence of Tween 80, we assume that our failure to obtain a mutant by using Casamino Acids medium was due to the absence of Tween in the selection medium. It is important to note that Tween 80 does not allow the BCG auxotrophs to form colonies on Casamino Acids medium. Based upon the AEC toxicity data, we can conclude that M. tuberculosis H37Rv does not transport lysine as effectively as does M. bovis BCG. Alternatively, since AEC toxicity requires transport of threonine as well, the AEC results could be explained by inefficient threonine transport. However, the high lysine requirement of the mutant and the dependency upon Tween 80 would support the former conclusion, since Tween 80 is believed to increase the permeability of the mycobacterial cell envelope (20). The primary phenotypic difference between the M. bovis BCG and M. tuberculosis mutants is that the M. bovis BCG mutants require lysine supplementation alone, while the M. tuberculosis mutant requires Tween 80 along with either lysine at a high concentration or Casamino Acids.
The auxotrophic mutants that we obtained in this study will be useful in a variety of applications. We hope to use the M. bovis BCG and M. tuberculosis lysine mutants for the construction of DAP auxotrophs (peptidoglycan mutants), as we have done for M. smegmatis (36). We are also developing a series of vectors bearing the lysA gene that could be used for the expression of foreign antigens in the BCG auxotrophs; the presence of the lysA gene would maintain the plasmids in vivo in the absence of antibiotic selection. We are also testing the behavior of the BCG mutants in animals in the hope that the mutants could be used in human immunodeficiency virus-infected populations as a safer alternative to live, wild-type BCG vaccine. One major goal of mycobacterial research is the development of attenuated strains of M. tuberculosis that could be used as potential vaccine strains. Such mutant strains would be unable to grow in a host, or would grow for only a short time, lasting long enough to prime the immune system. To this end, we are currently examining the growth kinetics of the M. tuberculosis auxotroph in animal models.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grants from the National Institutes of Health (AI26170 and AI33696), National Institute of Allergy and Infectious Diseases, National Institutes of Health, contract NO1-AI45244, to the Tuberculosis Research Unit, and a Burroughs Wellcome Fund Career Award in the Biomedical Sciences (M.S.P.).
We gratefully thank T. R. Weisbrod and J. Kriakov for DNA sequencing, M. Hondalus for M. tuberculosis H37Rv, G. Fennelly for M. bovis BCG substrain Connaught, J. McKinney and F. C.-Bange for strain MCK3037, S. Cole for cosY373, and R. P. Silver for critical reading of the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Present address: Department of Microbiology and Immunology, University of Rochester Medical Center, 601 Elmwood Ave., Box 672, Rochester, NY 14642. Phone: (716) 275-4670. Fax: (716) 473-9573. E-mail: Martin_Pavelka{at}urmc.rochester.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Aldovini, A.,
R. N. Husson, and R. A. Young.
1993.
The uraA locus and homologous recombination in Mycobacterium bovis BCG.
J. Bacteriol.
175:7282-7289 |
| 2. | Andersen, Å. B., and E. B. Hansen. 1993. Cloning of the lysA gene from Mycobacterium tuberculosis. Gene 124:105-109[Medline]. |
| 3. |
Azad, A. K.,
T. D. Sirakova,
L. M. Rogers, and P. E. Kolattukudy.
1996.
Targeted replacement of the mycocerosic acid synthase gene in Mycobacterium bovis BCG produces a mutant that lacks mycosides.
Proc. Natl. Acad. Sci. USA
93:4787-4792 |
| 4. |
Balasubramanian, V.,
M. S. Pavelka, Jr.,
S. S. Bardarov,
J. Martin,
T. R. Weisbrod,
R. A. McAdam,
B. R. Bloom, and W. R. Jacobs, Jr.
1996.
Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates.
J. Bacteriol.
178:273-279 |
| 5. | Bardarov, S., and W. R. Jacobs, Jr. 1995. Unpublished data. |
| 6. |
Bardarov, S. B.,
J. Kriakov,
C. Carriere,
S. Yu,
C. Vaamonde,
R. McAdam,
B. R. Bloom,
G. F. Hatfull, and W. R. Jacobs, Jr.
1997.
Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis.
Proc. Natl. Acad. Sci. USA
94:10961-10966 |
| 7. | Bardarov, S. B., T. R. Weisbrod, M. S. Pavelka, Jr., G. F. Hatfull, and W. R. Jacobs, Jr. 1998. Unpublished data. |
| 8. |
Berthet, F. X.,
M. Lagranderie,
P. Gounon,
C. Laurent-Winter,
D. Ensergueix,
P. Chavarot,
F. Thouron,
E. Maranghi,
V. Pelicic,
D. Portnoi,
G. Marchal, and B. Gicquel.
1998.
Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene.
Science
282:759-762 |
| 9. | Boyer, H., and D. Roulland-Dussoin. 1969. A complementation analysis of the restriction and modification of DNA in Escherichia coli. J. Mol. Biol. 41:459-472[Medline]. |
| 10. |
Cirillo, J. D.,
R. G. Barletta,
B. R. Bloom, and W. R. Jacobs, Jr.
1991.
A novel transposon trap for mycobacteria: isolation and characterization of IS1096.
J. Bacteriol.
173:7772-7780 |
| 11. | Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, B. G. Barrell, et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544[Medline]. (Erratum, 396:190.) |
| 12. | Difco-BRL. 1998. Personal communication. |
| 13. | Dolin, P. J., M. C. Raviglione, and A. Kochi. 1994. Global tuberculosis incidence and mortality during 1990-2000. Bull. W. H. O. 72:213-220[Medline]. |
| 14. |
Donnenberg, M. S., and J. B. Kaper.
1991.
Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive selection vector.
Infect. Immun.
59:4310-4317 |
| 15. | Erlich, J., and J. Blanchard. 1995. Unpublished data. |
| 16. | Glynias, M. J. 1991. Geneworks version 2.0. |
| 17. | Haas, D. W., and R. M. Des Prez. 1994. Tuberculosis and acquired immunodeficiency syndrome: a historical perspective on recent developments. Am. J. Med. 96:439-450[Medline]. |
| 18. | Hanahan, D. 1983. Studies of transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:557-580[Medline]. |
| 19. | Hatfull, G. F., J. J. Salvo, E. E. Falvey, V. Rimphanitchayakit, and N. D. Grindley. 1988. Site-specific recombination by the gamma delta resolvase, p. 149-181. In A. J. Kingsman, K. F. Chater, and S. M. Kingsman (ed.), Transposition. Cambridge University Press, Cambridge, United Kingdom. |
| 20. |
Hui, J.,
N. Gordon, and R. Kajioka.
1977.
Permeability barrier to rifampin in mycobacteria.
Antimicrob. Agents Chemother.
11:773-779 |
| 21. |
Ish-Horowicz, D., and J. F. Burke.
1981.
Rapid and efficient cosmid cloning.
Nucleic Acids Res.
9:2989-2998 |
| 22. | Jacobs, W. R., Jr., G. V. Kalpana, J. D. Cirillo, L. Pascopella, R. A. Udani, W. D. Jones, Jr., R. Barletta, and B. R. Bloom. 1991. Genetic systems for the mycobacteria. Methods Enzymol. 204:537-555[Medline]. |
| 23. |
Kalinowski, J.,
B. Bachmann,
G. Theirbach, and A. Pühler.
1990.
Aspartokinase genes lysC and lysC overlap and are adjacent to the aspartate -semialdehyde dehydrogenase gene asd in Corynebacterium glutamicum.
Mol. Gen. Genet.
224:317-324[Medline].
|
| 24. |
Kalpana, G. V.,
B. R. Bloom, and W. R. Jacobs, Jr.
1991.
Insertional mutagenesis and illegitimate recombination in mycobacteria.
Proc. Natl. Acad. Sci. USA
88:5433-5437 |
| 25. | Kalpana, G. V., W. R. Jacobs, Jr., and B. R. Bloom. 1990. Unpublished data. |
| 26. | Knipfer, N., A. Seth, and T. E. Shrader. 1997. Unmarked gene integration into the chromosome of Mycobacterium smegmatis via precise replacement of the pyrF gene. Plasmid 37:129-40[Medline]. |
| 27. |
Lee, M. H.,
L. Pascopella,
W. R. Jacobs, Jr., and G. F. Hatfull.
1991.
Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, BCG, and M. tuberculosis.
Proc. Natl. Acad. Sci. USA
88:3111-3115 |
| 28. | Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 29. |
Mateos, L. M.,
A. Pisabarro,
M. Patek,
M. Malumbres,
C. Guerrero,
B. J. Eikmanns,
H. Sahm, and J. F. Martin.
1994.
Transcriptional analysis and regulatory signals of the hom-thrB cluster of Brevibacterium lactofermentum.
J. Bacteriol.
176:7362-7371 |
| 30. | McAdam, R. A., T. R. Weisbrod, J. Martin, J. D. Scuderi, A. M. Brown, J. D. Cirillo, B. R. Bloom, and W. R. Jacobs, Jr. 1995. In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis. Infect. Immun. 63:1004-1012[Abstract]. |
| 31. | McFadden, J. 1996. Recombination in mycobacteria. Mol. Microbiol. 21:205-211[Medline]. |
| 32. | McKinney, J. D., F. C. Bange, and W. R. Jacobs, Jr. 1995. Unpublished data. |
| 33. | Mitchell, C., and B. R. Bloom. 1998. Personal communication. |
| 34. |
Oguiza, J. A.,
M. Malumbres,
G. Eriani,
A. Pisabarro,
L. M. Mateos,
F. Martin, and J. F. Martin.
1993.
A gene encoding arginyl-tRNA synthetase is located in the upstream region of the lysA gene in Brevobacterium lactofermentum: regulation of argS-lysA cluster expression by arginine.
J. Bacteriol.
175:7356-7362 |
| 35. | Patte, J.-C. 1996. Biosynthesis of threonine and lysine, p. 528-541. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. ASM Press, Washington, D.C. |
| 36. |
Pavelka, M. S., Jr., and W. R. Jacobs, Jr.
1996.
Biosynthesis of diaminopimelate, the precursor of lysine and a component of the peptidoglycan, is an essential function of Mycobacterium smegmatis.
J. Bacteriol.
178:6496-6507 |
| 37. |
Pelicic, V.,
M. Jackson,
J. M. Reyrat,
W. R. Jacobs, Jr.,
B. Gicquel, and C. Guilhot.
1997.
Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis.
Proc. Natl. Acad. Sci. USA
94:10955-10960 |
| 38. |
Pelicic, V.,
J. M. Reyrat, and B. Gicquel.
1996.
Expression of the Bacillus subtilis sacB gene confers sucrose sensitivity on mycobacteria.
J. Bacteriol.
178:1197-1199 |
| 39. | Pelicic, V., J. M. Reyrat, and B. Gicquel. 1996. Generation of unmarked directed mutations in mycobacteria, using sucrose counter-selectable suicide vectors. Mol. Microbiol. 20:919-925[Medline]. |
| 40. | Pelicic, V., J. M. Reyrat, and B. Gicquel. 1996. Positive selection of allelic exchange mutants in Mycobacterium bovis BCG. FEMS Microbiol. Lett. 144:161-166[Medline]. |
| 41. |
Reyrat, J.-M.,
F.-X. Berthet, and B. Gicquel.
1995.
The urease locus of Mycobacterium tuberculosis and its utilization for the demonstration of allelic exchange in Mycobacterium bovis bacillus Calmette-Guérin.
Proc. Natl. Acad. Sci. USA
92:8768-8772 |
| 42. | Sander, P., A. Meier, and E. C. Böttger. 1995. rpsL+: a dominant selectable marker for gene replacement in mycobacteria. Mol. Microbiol. 16:991-1000[Medline]. |
| 43. | Sanger Centre M. tuberculosis H37Rv Genome Project. 22 March 1999, revision date. [Online.] http://www.sanger.ac.uk/Projects/M_tuberculosis/. [6 April 1999, last date accessed.] |
| 44. | Sano, K., and I. Shiio. 1970. Microbial production of L-lysine. III. Production of mutants resistant to S-(-2-aminoethyl)-L-cysteine. J. Gen. Appl. Microbiol. 16:373-391. |
| 45. | Seep-Feldhaus, A. H., J. Kalinowski, and A. Puhler. 1991. Molecular analysis of the Corynebacterium glutamicum lysL gene involved in lysine uptake. Mol. Microbiol. 5:2995-3005[Medline]. |
| 46. | Snapper, S. B., R. E. Melton, S. Mustafa, T. Kieser, and W. R. Jacobs, Jr. 1990. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol. Microbiol. 4:1911-1919[Medline]. |
| 47. | Snider, D. E., M. Raviglione, and A. Kochi. 1994. Global burden of tuberculosis, p. 3-11. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C. |
| 48. |
Steffes, C.,
J. Ellis,
J. Wu, and B. P. Rosen.
1992.
The lysP gene encodes the lysine-specific permease.
J. Bacteriol.
174:3242-3249 |
| 49. | Steinmetz, M., D. Le Coq, S. Aymerich, G. Gonzy-Treboul, and P. Gay. 1985. The DNA sequence of the gene for the secreted Bacillus subtilis enzyme levansucrase and its genetic control sites. Mol. Gen. Genet. 200:220-228[Medline]. |
| 50. | Stover, C. K., V. F. de la Cruz, T. R. Fuerst, J. E. Burlein, L. A. Benson, L. T. Bennett, G. P. Bansal, J. F. Young, M. H. Lee, G. F. Hatfull, S. B. Snapper, R. G. Barletta, W. R. Jacobs, Jr., and B. R. Bloom. 1991. New use of BCG for recombinant vaccines. Nature 351:456-460[Medline]. |
| 51. | Umbarger, H. E. 1978. Amino acid biosynthesis and its regulation. Annu. Rev. Biochem. 47:533-606. |
This article has been cited by other articles: